Michael A. Samuel, MD, discusses new developments in the use of a microcatheter (iTrack 275, iScience) for site-specific delivery of CNTO2476 stem cell therapy to the subretinal space. Dr. Samuel is chairman of the executive committee of the Retina Institute of California as well and the chief scientific officer of the California Center for Clinical Research.

1,110 video views and 20,617 series views since

  • Bookmark
  • QuickLink